Compare Bristol-Myers Squibb (BRM) vs. Competitors

20 Followers

Comparison Results

BRM

Bristol-Myers Squibb

€57.74

€106.89B

13.13

36.10%

8 Buy

12 Hold

1 Sell

Moderate Buy

Amgen

$442.24

$217.86B

24.82

36.88%

9 Buy

16 Hold

2 Sell

Moderate Buy

Eli Lilly & Co

$1233.66

$1.08T

38.72

36.97%

20 Buy

2 Hold

1 Sell

Strong Buy

Merck & Company

$156.45

$344.27B

112.64

59.84%

14 Buy

6 Hold

0 Sell

Moderate Buy

Novartis

$159.98

$255.98B

21.36

6.46%

3 Buy

3 Hold

1 Sell

Moderate Buy

AbbVie

$265.79

$469.63B

75.16

15.86%

19 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

BRM vs ABBV

xxxxxxxxxxxxx

Performance Comparison

DE:BRM

Bristol-Myers Squibb

52.67

15.78

42.78%

AMGN

Amgen

402.60

115.04

40.00%

LLY

Eli Lilly & Co

1,157.49

319.15

38.07%

MRK

Merck & Company

141.94

56.83

66.77%

NVS

Novartis

140.79

11.77

9.12%

ABBV

AbbVie

266.69

40.87

18.10%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >